Home News Insights Trading halts Paper trading Guide Community My account

Market calendarChecking market schedule

Display in USD

Loading news article.

About WAPE
U.S. stock guide
Scanner guide
Paper trading guide
Terms of service
Privacy policy
Announcements
FAQ

Support: help@wapeb.comPartnerships: partnership@wapeb.com

WAPE is a free research, analysis and paper trading service. It does not place real securities orders. Market data and AI summaries are for information only, not investment advice or stock recommendations. Information may include delays, errors or estimates. Check original sources and supporting materials. You are responsible for your investment decisions and any resulting gains or losses.

Language한국어 English

Loading news article.

Quoin Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2026 Financial Results | WAPE

Back All news

NewsGlobeNewswire

Quoin Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2026 Financial Results

Nov 5, 2026, 08:30 ET · Published

View source

Article summary

Quoin reports Q3 2026 results, positive interim Phase 2/3 QRX003 data in Netherton Syndrome, up to $50M private placement and new PSS designations.

An excerpt from the original article.

Related companies

Quoin Pharmaceuticals, Ltd. American Depositary SharesQNRXView stock

Quoin Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2026 Financial Results

Article summary

Related companies

Analyzed by WAPE AI.

Comments —